Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 3/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL459488 | 1.00 | PDE4B (0.44) | PDE4BNR1H2USP30EPHX1CTSK | |
| SCHEMBL21052130 | 1.00 | PDE4B (0.44) | PDE4BNR1H2USP30EPHX1CTSK | |
| SCHEMBL21092354 | 0.91 | PDE4B (0.38) | PDE4BNR1H2USP30EPHX1MAOA | |
| SCHEMBL3621440 | 0.90 | CTSK (0.36) | PDE4BUSP30CTSKCA1CA2 | |
| SCHEMBL18811768 | 0.84 | NR1H2 (0.47) | NR1H2EPHX1USP2SMN1; SMN2GPR119 | |
| SCHEMBL18811702 | 0.84 | NR1H2 (0.47) | NR1H2EPHX1USP2SMN1; SMN2GPR119 | |
| SCHEMBL2933886 | 0.84 | NR1H2 (0.47) | NR1H2EPHX1USP2SMN1; SMN2GPR119 | |
| SCHEMBL15805570 | 0.83 | PDE4B (0.47) | PDE4BNR1H2USP30EPHX1CTSK | |
| SCHEMBL20479586 | 0.82 | PDE4B (0.47) | PDE4BUSP30CTSKCA1CA2 | |
| SCHEMBL20479584 | 0.82 | PDE4B (0.47) | PDE4BUSP30CTSKCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019111218-A1 | NOVEL HETEROCYCLIC COMPOUNDS AS IRAK4 INHIBITORS | CADILA HEALTHCARE LIMITED (IN) | 2019-06-13 | — | — | WO | disclosed |